nodes	percent_of_prediction	percent_of_DWPC	metapath
Auranofin—ALB—atherosclerosis	0.493	1	CbGaD
Auranofin—ALB—Rosuvastatin—atherosclerosis	0.0939	1	CbGbCtD
Auranofin—Interstitial lung disease—Ezetimibe—atherosclerosis	0.00396	0.0263	CcSEcCtD
Auranofin—Proteinuria—Rosuvastatin—atherosclerosis	0.00384	0.0255	CcSEcCtD
Auranofin—Protein urine present—Rosuvastatin—atherosclerosis	0.00378	0.0252	CcSEcCtD
Auranofin—Interstitial lung disease—Simvastatin—atherosclerosis	0.00377	0.0251	CcSEcCtD
Auranofin—Hepatic enzyme increased—Rosuvastatin—atherosclerosis	0.00356	0.0237	CcSEcCtD
Auranofin—Interstitial lung disease—Pravastatin—atherosclerosis	0.00341	0.0227	CcSEcCtD
Auranofin—PRDX5—connective tissue—atherosclerosis	0.00325	0.191	CbGeAlD
Auranofin—Proteinuria—Simvastatin—atherosclerosis	0.00304	0.0202	CcSEcCtD
Auranofin—Protein urine present—Simvastatin—atherosclerosis	0.003	0.0199	CcSEcCtD
Auranofin—PRDX5—cardiovascular system—atherosclerosis	0.00283	0.166	CbGeAlD
Auranofin—PRDX5—adipose tissue—atherosclerosis	0.0025	0.146	CbGeAlD
Auranofin—IKBKB—connective tissue—atherosclerosis	0.00193	0.113	CbGeAlD
Auranofin—Neuropathy peripheral—Rosuvastatin—atherosclerosis	0.00185	0.0123	CcSEcCtD
Auranofin—Jaundice—Rosuvastatin—atherosclerosis	0.00184	0.0122	CcSEcCtD
Auranofin—Haematuria—Rosuvastatin—atherosclerosis	0.0018	0.012	CcSEcCtD
Auranofin—Gastrointestinal haemorrhage—Niacin—atherosclerosis	0.00178	0.0118	CcSEcCtD
Auranofin—Eosinophilia—Lovastatin—atherosclerosis	0.00177	0.0118	CcSEcCtD
Auranofin—PRDX5—liver—atherosclerosis	0.00175	0.103	CbGeAlD
Auranofin—Eosinophilia—Ezetimibe—atherosclerosis	0.00174	0.0116	CcSEcCtD
Auranofin—IKBKB—cardiovascular system—atherosclerosis	0.00168	0.0983	CbGeAlD
Auranofin—Eosinophilia—Simvastatin—atherosclerosis	0.00166	0.011	CcSEcCtD
Auranofin—Neuropathy peripheral—Lovastatin—atherosclerosis	0.00157	0.0104	CcSEcCtD
Auranofin—Dysphagia—Niacin—atherosclerosis	0.00154	0.0102	CcSEcCtD
Auranofin—Neuropathy peripheral—Ezetimibe—atherosclerosis	0.00154	0.0102	CcSEcCtD
Auranofin—Jaundice—Ezetimibe—atherosclerosis	0.00153	0.0102	CcSEcCtD
Auranofin—Eosinophilia—Pravastatin—atherosclerosis	0.0015	0.00998	CcSEcCtD
Auranofin—IKBKB—adipose tissue—atherosclerosis	0.00148	0.0867	CbGeAlD
Auranofin—Neuropathy peripheral—Simvastatin—atherosclerosis	0.00146	0.00974	CcSEcCtD
Auranofin—Jaundice—Simvastatin—atherosclerosis	0.00146	0.00969	CcSEcCtD
Auranofin—Flatulence—Rosuvastatin—atherosclerosis	0.00145	0.00966	CcSEcCtD
Auranofin—Weight decreased—Pravastatin—atherosclerosis	0.00137	0.00912	CcSEcCtD
Auranofin—Angioedema—Rosuvastatin—atherosclerosis	0.00135	0.00896	CcSEcCtD
Auranofin—Stomatitis—Niacin—atherosclerosis	0.00134	0.0089	CcSEcCtD
Auranofin—Jaundice—Niacin—atherosclerosis	0.00134	0.0089	CcSEcCtD
Auranofin—Neuropathy peripheral—Pravastatin—atherosclerosis	0.00132	0.00881	CcSEcCtD
Auranofin—Jaundice—Pravastatin—atherosclerosis	0.00132	0.00876	CcSEcCtD
Auranofin—Alopecia—Lovastatin—atherosclerosis	0.00127	0.00843	CcSEcCtD
Auranofin—Alopecia—Ezetimibe—atherosclerosis	0.00124	0.00827	CcSEcCtD
Auranofin—Flatulence—Lovastatin—atherosclerosis	0.00123	0.00818	CcSEcCtD
Auranofin—Dysgeusia—Lovastatin—atherosclerosis	0.00122	0.00813	CcSEcCtD
Auranofin—Flatulence—Ezetimibe—atherosclerosis	0.00121	0.00803	CcSEcCtD
Auranofin—Visual impairment—Niacin—atherosclerosis	0.00119	0.0079	CcSEcCtD
Auranofin—Alopecia—Simvastatin—atherosclerosis	0.00119	0.00789	CcSEcCtD
Auranofin—Thrombocytopenia—Rosuvastatin—atherosclerosis	0.00118	0.00783	CcSEcCtD
Auranofin—Visual impairment—Pravastatin—atherosclerosis	0.00117	0.00778	CcSEcCtD
Auranofin—Eye disorder—Niacin—atherosclerosis	0.00115	0.00766	CcSEcCtD
Auranofin—Flatulence—Simvastatin—atherosclerosis	0.00115	0.00766	CcSEcCtD
Auranofin—Dysgeusia—Simvastatin—atherosclerosis	0.00114	0.00761	CcSEcCtD
Auranofin—Angioedema—Lovastatin—atherosclerosis	0.00114	0.00759	CcSEcCtD
Auranofin—Anaemia—Ezetimibe—atherosclerosis	0.00113	0.00753	CcSEcCtD
Auranofin—Angioedema—Ezetimibe—atherosclerosis	0.00112	0.00744	CcSEcCtD
Auranofin—Leukopenia—Lovastatin—atherosclerosis	0.00112	0.00743	CcSEcCtD
Auranofin—Alopecia—Niacin—atherosclerosis	0.00109	0.00724	CcSEcCtD
Auranofin—Anaemia—Simvastatin—atherosclerosis	0.00108	0.00718	CcSEcCtD
Auranofin—Alopecia—Pravastatin—atherosclerosis	0.00107	0.00713	CcSEcCtD
Auranofin—Angioedema—Simvastatin—atherosclerosis	0.00107	0.0071	CcSEcCtD
Auranofin—Dyspepsia—Rosuvastatin—atherosclerosis	0.00106	0.00704	CcSEcCtD
Auranofin—Flatulence—Niacin—atherosclerosis	0.00106	0.00703	CcSEcCtD
Auranofin—Leukopenia—Simvastatin—atherosclerosis	0.00105	0.00695	CcSEcCtD
Auranofin—Flatulence—Pravastatin—atherosclerosis	0.00104	0.00692	CcSEcCtD
Auranofin—IKBKB—liver—atherosclerosis	0.00104	0.0608	CbGeAlD
Auranofin—Dysgeusia—Pravastatin—atherosclerosis	0.00103	0.00688	CcSEcCtD
Auranofin—Constipation—Rosuvastatin—atherosclerosis	0.00103	0.00684	CcSEcCtD
Auranofin—Thrombocytopenia—Lovastatin—atherosclerosis	0.000998	0.00664	CcSEcCtD
Auranofin—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.000983	0.00654	CcSEcCtD
Auranofin—Angioedema—Niacin—atherosclerosis	0.00098	0.00652	CcSEcCtD
Auranofin—Thrombocytopenia—Ezetimibe—atherosclerosis	0.000979	0.00651	CcSEcCtD
Auranofin—Anaemia—Pravastatin—atherosclerosis	0.000976	0.00649	CcSEcCtD
Auranofin—Anorexia—Lovastatin—atherosclerosis	0.000971	0.00646	CcSEcCtD
Auranofin—Angioedema—Pravastatin—atherosclerosis	0.000965	0.00642	CcSEcCtD
Auranofin—Leukopenia—Niacin—atherosclerosis	0.00096	0.00639	CcSEcCtD
Auranofin—Urticaria—Rosuvastatin—atherosclerosis	0.000955	0.00635	CcSEcCtD
Auranofin—Abdominal pain—Rosuvastatin—atherosclerosis	0.000951	0.00632	CcSEcCtD
Auranofin—Leukopenia—Pravastatin—atherosclerosis	0.000945	0.00629	CcSEcCtD
Auranofin—Thrombocytopenia—Simvastatin—atherosclerosis	0.000933	0.00621	CcSEcCtD
Auranofin—Anorexia—Simvastatin—atherosclerosis	0.000909	0.00604	CcSEcCtD
Auranofin—Dyspepsia—Lovastatin—atherosclerosis	0.000897	0.00597	CcSEcCtD
Auranofin—Decreased appetite—Lovastatin—atherosclerosis	0.000886	0.00589	CcSEcCtD
Auranofin—Dyspepsia—Ezetimibe—atherosclerosis	0.00088	0.00585	CcSEcCtD
Auranofin—Constipation—Lovastatin—atherosclerosis	0.000871	0.0058	CcSEcCtD
Auranofin—Decreased appetite—Ezetimibe—atherosclerosis	0.000869	0.00578	CcSEcCtD
Auranofin—Constipation—Ezetimibe—atherosclerosis	0.000855	0.00569	CcSEcCtD
Auranofin—Pruritus—Rosuvastatin—atherosclerosis	0.000851	0.00566	CcSEcCtD
Auranofin—Thrombocytopenia—Pravastatin—atherosclerosis	0.000844	0.00561	CcSEcCtD
Auranofin—Dyspepsia—Simvastatin—atherosclerosis	0.000839	0.00558	CcSEcCtD
Auranofin—Anorexia—Niacin—atherosclerosis	0.000834	0.00555	CcSEcCtD
Auranofin—Gastrointestinal pain—Lovastatin—atherosclerosis	0.000833	0.00554	CcSEcCtD
Auranofin—Decreased appetite—Simvastatin—atherosclerosis	0.000829	0.00551	CcSEcCtD
Auranofin—Diarrhoea—Rosuvastatin—atherosclerosis	0.000823	0.00547	CcSEcCtD
Auranofin—Anorexia—Pravastatin—atherosclerosis	0.000821	0.00546	CcSEcCtD
Auranofin—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.000817	0.00544	CcSEcCtD
Auranofin—Constipation—Simvastatin—atherosclerosis	0.000815	0.00542	CcSEcCtD
Auranofin—Urticaria—Lovastatin—atherosclerosis	0.000809	0.00538	CcSEcCtD
Auranofin—Abdominal pain—Lovastatin—atherosclerosis	0.000806	0.00536	CcSEcCtD
Auranofin—Urticaria—Ezetimibe—atherosclerosis	0.000794	0.00528	CcSEcCtD
Auranofin—Abdominal pain—Ezetimibe—atherosclerosis	0.00079	0.00526	CcSEcCtD
Auranofin—Gastrointestinal pain—Simvastatin—atherosclerosis	0.000779	0.00518	CcSEcCtD
Auranofin—Dyspepsia—Niacin—atherosclerosis	0.00077	0.00512	CcSEcCtD
Auranofin—Decreased appetite—Niacin—atherosclerosis	0.000761	0.00506	CcSEcCtD
Auranofin—Dyspepsia—Pravastatin—atherosclerosis	0.000759	0.00505	CcSEcCtD
Auranofin—Rash—Rosuvastatin—atherosclerosis	0.000758	0.00504	CcSEcCtD
Auranofin—Dermatitis—Rosuvastatin—atherosclerosis	0.000757	0.00504	CcSEcCtD
Auranofin—Urticaria—Simvastatin—atherosclerosis	0.000757	0.00504	CcSEcCtD
Auranofin—Abdominal pain—Simvastatin—atherosclerosis	0.000753	0.00501	CcSEcCtD
Auranofin—Decreased appetite—Pravastatin—atherosclerosis	0.000749	0.00498	CcSEcCtD
Auranofin—Constipation—Pravastatin—atherosclerosis	0.000737	0.0049	CcSEcCtD
Auranofin—Pruritus—Lovastatin—atherosclerosis	0.000721	0.0048	CcSEcCtD
Auranofin—Gastrointestinal pain—Niacin—atherosclerosis	0.000716	0.00476	CcSEcCtD
Auranofin—Nausea—Rosuvastatin—atherosclerosis	0.000714	0.00475	CcSEcCtD
Auranofin—Pruritus—Ezetimibe—atherosclerosis	0.000707	0.0047	CcSEcCtD
Auranofin—Gastrointestinal pain—Pravastatin—atherosclerosis	0.000705	0.00469	CcSEcCtD
Auranofin—Diarrhoea—Lovastatin—atherosclerosis	0.000697	0.00464	CcSEcCtD
Auranofin—Urticaria—Niacin—atherosclerosis	0.000695	0.00462	CcSEcCtD
Auranofin—Abdominal pain—Niacin—atherosclerosis	0.000692	0.0046	CcSEcCtD
Auranofin—Urticaria—Pravastatin—atherosclerosis	0.000685	0.00455	CcSEcCtD
Auranofin—Diarrhoea—Ezetimibe—atherosclerosis	0.000684	0.00455	CcSEcCtD
Auranofin—Abdominal pain—Pravastatin—atherosclerosis	0.000681	0.00453	CcSEcCtD
Auranofin—Pruritus—Simvastatin—atherosclerosis	0.000674	0.00449	CcSEcCtD
Auranofin—Diarrhoea—Simvastatin—atherosclerosis	0.000652	0.00434	CcSEcCtD
Auranofin—Vomiting—Lovastatin—atherosclerosis	0.000648	0.00431	CcSEcCtD
Auranofin—Rash—Lovastatin—atherosclerosis	0.000642	0.00427	CcSEcCtD
Auranofin—Dermatitis—Lovastatin—atherosclerosis	0.000642	0.00427	CcSEcCtD
Auranofin—Vomiting—Ezetimibe—atherosclerosis	0.000635	0.00423	CcSEcCtD
Auranofin—Rash—Ezetimibe—atherosclerosis	0.00063	0.00419	CcSEcCtD
Auranofin—Dermatitis—Ezetimibe—atherosclerosis	0.00063	0.00419	CcSEcCtD
Auranofin—Pruritus—Niacin—atherosclerosis	0.000619	0.00412	CcSEcCtD
Auranofin—Pruritus—Pravastatin—atherosclerosis	0.00061	0.00406	CcSEcCtD
Auranofin—Vomiting—Simvastatin—atherosclerosis	0.000606	0.00403	CcSEcCtD
Auranofin—ALB—liver—atherosclerosis	0.000605	0.0355	CbGeAlD
Auranofin—Nausea—Lovastatin—atherosclerosis	0.000605	0.00403	CcSEcCtD
Auranofin—Rash—Simvastatin—atherosclerosis	0.000601	0.004	CcSEcCtD
Auranofin—Dermatitis—Simvastatin—atherosclerosis	0.0006	0.00399	CcSEcCtD
Auranofin—Diarrhoea—Niacin—atherosclerosis	0.000599	0.00398	CcSEcCtD
Auranofin—Nausea—Ezetimibe—atherosclerosis	0.000594	0.00395	CcSEcCtD
Auranofin—Diarrhoea—Pravastatin—atherosclerosis	0.00059	0.00392	CcSEcCtD
Auranofin—Nausea—Simvastatin—atherosclerosis	0.000566	0.00377	CcSEcCtD
Auranofin—Vomiting—Niacin—atherosclerosis	0.000556	0.0037	CcSEcCtD
Auranofin—Rash—Niacin—atherosclerosis	0.000552	0.00367	CcSEcCtD
Auranofin—Dermatitis—Niacin—atherosclerosis	0.000551	0.00367	CcSEcCtD
Auranofin—Vomiting—Pravastatin—atherosclerosis	0.000548	0.00364	CcSEcCtD
Auranofin—Rash—Pravastatin—atherosclerosis	0.000543	0.00361	CcSEcCtD
Auranofin—Dermatitis—Pravastatin—atherosclerosis	0.000543	0.00361	CcSEcCtD
Auranofin—Nausea—Niacin—atherosclerosis	0.00052	0.00346	CcSEcCtD
Auranofin—Nausea—Pravastatin—atherosclerosis	0.000512	0.0034	CcSEcCtD
Auranofin—IKBKB—MAPK Signaling Pathway—MAPK3—atherosclerosis	6.88e-05	0.00028	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—ABCG5—atherosclerosis	6.83e-05	0.000278	CbGpPWpGaD
Auranofin—ALB—Hemostasis—THBD—atherosclerosis	6.82e-05	0.000278	CbGpPWpGaD
Auranofin—ALB—Transmembrane transport of small molecules—TRPV1—atherosclerosis	6.75e-05	0.000275	CbGpPWpGaD
Auranofin—IKBKB—MAPK Signaling Pathway—TGFB1—atherosclerosis	6.67e-05	0.000272	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—VCAM1—atherosclerosis	6.65e-05	0.000271	CbGpPWpGaD
Auranofin—ALB—Platelet activation, signaling and aggregation—PRKCG—atherosclerosis	6.63e-05	0.00027	CbGpPWpGaD
Auranofin—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—atherosclerosis	6.62e-05	0.00027	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—LPA—atherosclerosis	6.6e-05	0.000269	CbGpPWpGaD
Auranofin—IKBKB—Fc epsilon receptor (FCERI) signaling—MAPK3—atherosclerosis	6.59e-05	0.000269	CbGpPWpGaD
Auranofin—ALB—Transmembrane transport of small molecules—ABCG5—atherosclerosis	6.5e-05	0.000265	CbGpPWpGaD
Auranofin—IKBKB—Toll Like Receptor 4 (TLR4) Cascade—IL6—atherosclerosis	6.49e-05	0.000265	CbGpPWpGaD
Auranofin—ALB—Platelet activation, signaling and aggregation—CD36—atherosclerosis	6.48e-05	0.000264	CbGpPWpGaD
Auranofin—ALB—Hemostasis—SELE—atherosclerosis	6.46e-05	0.000263	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—SOCS3—atherosclerosis	6.45e-05	0.000263	CbGpPWpGaD
Auranofin—IKBKB—Cytokine Signaling in Immune system—IFNG—atherosclerosis	6.4e-05	0.000261	CbGpPWpGaD
Auranofin—ALB—Platelet degranulation—TGFB1—atherosclerosis	6.38e-05	0.00026	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—APOA5—atherosclerosis	6.33e-05	0.000258	CbGpPWpGaD
Auranofin—IKBKB—MAPK Signaling Pathway—TNF—atherosclerosis	6.23e-05	0.000254	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—PLA2G1B—atherosclerosis	6.09e-05	0.000248	CbGpPWpGaD
Auranofin—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—atherosclerosis	6.08e-05	0.000248	CbGpPWpGaD
Auranofin—ALB—Metabolism—LDLRAP1—atherosclerosis	6.02e-05	0.000245	CbGpPWpGaD
Auranofin—ALB—Platelet activation, signaling and aggregation—PDGFB—atherosclerosis	5.97e-05	0.000244	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—ALOX5—atherosclerosis	5.88e-05	0.00024	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—AGER—atherosclerosis	5.88e-05	0.00024	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—CD40LG—atherosclerosis	5.86e-05	0.000239	CbGpPWpGaD
Auranofin—IKBKB—Regulation of toll-like receptor signaling pathway—IL6—atherosclerosis	5.85e-05	0.000238	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—PRKCG—atherosclerosis	5.82e-05	0.000237	CbGpPWpGaD
Auranofin—IKBKB—Toll-Like Receptors Cascades—IL6—atherosclerosis	5.78e-05	0.000236	CbGpPWpGaD
Auranofin—ALB—Hemostasis—VWF—atherosclerosis	5.76e-05	0.000235	CbGpPWpGaD
Auranofin—IKBKB—Cytokine Signaling in Immune system—IL1B—atherosclerosis	5.7e-05	0.000232	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—CD36—atherosclerosis	5.69e-05	0.000232	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—APOA4—atherosclerosis	5.66e-05	0.000231	CbGpPWpGaD
Auranofin—ALB—Metabolism—PLTP—atherosclerosis	5.66e-05	0.000231	CbGpPWpGaD
Auranofin—ALB—Platelet activation, signaling and aggregation—APOA1—atherosclerosis	5.65e-05	0.00023	CbGpPWpGaD
Auranofin—ALB—Folate Metabolism—IL6—atherosclerosis	5.61e-05	0.000229	CbGpPWpGaD
Auranofin—ALB—Selenium Micronutrient Network—TNF—atherosclerosis	5.52e-05	0.000225	CbGpPWpGaD
Auranofin—ALB—Hemostasis—F7—atherosclerosis	5.49e-05	0.000224	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—CD36—atherosclerosis	5.46e-05	0.000223	CbGpPWpGaD
Auranofin—IKBKB—Regulation of toll-like receptor signaling pathway—AKT1—atherosclerosis	5.4e-05	0.00022	CbGpPWpGaD
Auranofin—ALB—Platelet activation, signaling and aggregation—F2—atherosclerosis	5.39e-05	0.00022	CbGpPWpGaD
Auranofin—IKBKB—Cytokine Signaling in Immune system—NFKB1—atherosclerosis	5.32e-05	0.000217	CbGpPWpGaD
Auranofin—IKBKB—Immune System—NCF1—atherosclerosis	5.28e-05	0.000215	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—PDGFB—atherosclerosis	5.25e-05	0.000214	CbGpPWpGaD
Auranofin—IKBKB—BDNF signaling pathway—AKT1—atherosclerosis	5.25e-05	0.000214	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—LIPC—atherosclerosis	5.24e-05	0.000214	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—NFKB1—atherosclerosis	5.23e-05	0.000213	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—CCL4—atherosclerosis	5.22e-05	0.000213	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—APOC3—atherosclerosis	5.21e-05	0.000212	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—LDLR—atherosclerosis	5.18e-05	0.000211	CbGpPWpGaD
Auranofin—ALB—Platelet activation, signaling and aggregation—PIK3CG—atherosclerosis	5.16e-05	0.00021	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—MAPK8—atherosclerosis	5.14e-05	0.00021	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—CRP—atherosclerosis	5.13e-05	0.000209	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—CETP—atherosclerosis	5.06e-05	0.000206	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—PDGFB—atherosclerosis	5.04e-05	0.000205	CbGpPWpGaD
Auranofin—IKBKB—Immune System—CCR2—atherosclerosis	4.99e-05	0.000203	CbGpPWpGaD
Auranofin—IKBKB—Immune System—CYBA—atherosclerosis	4.96e-05	0.000202	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—TLR4—atherosclerosis	4.92e-05	0.0002	CbGpPWpGaD
Auranofin—ALB—Metabolism—ABCG8—atherosclerosis	4.91e-05	0.0002	CbGpPWpGaD
Auranofin—ALB—Metabolism—LTA4H—atherosclerosis	4.91e-05	0.0002	CbGpPWpGaD
Auranofin—ALB—Hemostasis—PLAT—atherosclerosis	4.9e-05	0.0002	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—APOA2—atherosclerosis	4.87e-05	0.000199	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—SCARB1—atherosclerosis	4.84e-05	0.000197	CbGpPWpGaD
Auranofin—IKBKB—Insulin Signaling—AKT1—atherosclerosis	4.82e-05	0.000197	CbGpPWpGaD
Auranofin—IKBKB—Fc epsilon receptor (FCERI) signaling—IL6—atherosclerosis	4.82e-05	0.000196	CbGpPWpGaD
Auranofin—ALB—Transmembrane transport of small molecules—CETP—atherosclerosis	4.81e-05	0.000196	CbGpPWpGaD
Auranofin—IKBKB—Cytokine Signaling in Immune system—STAT3—atherosclerosis	4.78e-05	0.000195	CbGpPWpGaD
Auranofin—ALB—Platelet activation, signaling and aggregation—IGF1—atherosclerosis	4.72e-05	0.000192	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—STAT3—atherosclerosis	4.7e-05	0.000192	CbGpPWpGaD
Auranofin—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—AKT1—atherosclerosis	4.66e-05	0.00019	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—UTS2—atherosclerosis	4.65e-05	0.00019	CbGpPWpGaD
Auranofin—IKBKB—MAPK Signaling Pathway—AKT1—atherosclerosis	4.64e-05	0.000189	CbGpPWpGaD
Auranofin—IKBKB—Immune System—CD40—atherosclerosis	4.63e-05	0.000189	CbGpPWpGaD
Auranofin—IKBKB—Immune System—TLR2—atherosclerosis	4.63e-05	0.000189	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—HMGCR—atherosclerosis	4.57e-05	0.000186	CbGpPWpGaD
Auranofin—IKBKB—Cytokine Signaling in Immune system—MAPK3—atherosclerosis	4.57e-05	0.000186	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—ICAM1—atherosclerosis	4.53e-05	0.000184	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—MAPK3—atherosclerosis	4.49e-05	0.000183	CbGpPWpGaD
Auranofin—ALB—Platelet activation, signaling and aggregation—SERPINE1—atherosclerosis	4.48e-05	0.000183	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—CX3CR1—atherosclerosis	4.46e-05	0.000182	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—CASR—atherosclerosis	4.46e-05	0.000182	CbGpPWpGaD
Auranofin—ALB—Selenium Micronutrient Network—IL6—atherosclerosis	4.46e-05	0.000182	CbGpPWpGaD
Auranofin—IKBKB—Fc epsilon receptor (FCERI) signaling—AKT1—atherosclerosis	4.45e-05	0.000181	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—CX3CL1—atherosclerosis	4.37e-05	0.000178	CbGpPWpGaD
Auranofin—ALB—Hemostasis—KNG1—atherosclerosis	4.3e-05	0.000175	CbGpPWpGaD
Auranofin—ALB—Hemostasis—PLAUR—atherosclerosis	4.26e-05	0.000174	CbGpPWpGaD
Auranofin—ALB—Transmembrane transport of small molecules—PLAT—atherosclerosis	4.24e-05	0.000173	CbGpPWpGaD
Auranofin—IKBKB—Immune System—CD14—atherosclerosis	4.18e-05	0.00017	CbGpPWpGaD
Auranofin—ALB—Hemostasis—PLG—atherosclerosis	4.16e-05	0.00017	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—CNR2—atherosclerosis	4.14e-05	0.000169	CbGpPWpGaD
Auranofin—IKBKB—B Cell Activation—AKT1—atherosclerosis	4.12e-05	0.000168	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—ABCA1—atherosclerosis	4.08e-05	0.000166	CbGpPWpGaD
Auranofin—IKBKB—Immune System—VCAM1—atherosclerosis	4.03e-05	0.000164	CbGpPWpGaD
Auranofin—ALB—Hemostasis—SOD1—atherosclerosis	3.99e-05	0.000163	CbGpPWpGaD
Auranofin—IKBKB—Immune System—SOCS3—atherosclerosis	3.91e-05	0.000159	CbGpPWpGaD
Auranofin—ALB—Metabolism—ABCG1—atherosclerosis	3.88e-05	0.000158	CbGpPWpGaD
Auranofin—ALB—Hemostasis—IGF2—atherosclerosis	3.79e-05	0.000155	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—VWF—atherosclerosis	3.69e-05	0.000151	CbGpPWpGaD
Auranofin—ALB—Hemostasis—APOB—atherosclerosis	3.68e-05	0.00015	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—APOC3—atherosclerosis	3.67e-05	0.00015	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—LDLR—atherosclerosis	3.65e-05	0.000149	CbGpPWpGaD
Auranofin—ALB—Metabolism—LCAT—atherosclerosis	3.65e-05	0.000149	CbGpPWpGaD
Auranofin—ALB—Metabolism—FABP4—atherosclerosis	3.65e-05	0.000149	CbGpPWpGaD
Auranofin—ALB—Transmembrane transport of small molecules—PLG—atherosclerosis	3.6e-05	0.000147	CbGpPWpGaD
Auranofin—ALB—Metabolism—APOA4—atherosclerosis	3.58e-05	0.000146	CbGpPWpGaD
Auranofin—IKBKB—Immune System—IL18—atherosclerosis	3.57e-05	0.000145	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—CCL3—atherosclerosis	3.56e-05	0.000145	CbGpPWpGaD
Auranofin—IKBKB—Immune System—CD40LG—atherosclerosis	3.55e-05	0.000145	CbGpPWpGaD
Auranofin—ALB—Metabolism—CYP7A1—atherosclerosis	3.52e-05	0.000143	CbGpPWpGaD
Auranofin—IKBKB—Immune System—AGER—atherosclerosis	3.43e-05	0.00014	CbGpPWpGaD
Auranofin—ALB—Hemostasis—PRKCG—atherosclerosis	3.42e-05	0.000139	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—NCF1—atherosclerosis	3.41e-05	0.000139	CbGpPWpGaD
Auranofin—IKBKB—Immune System—PRKCG—atherosclerosis	3.39e-05	0.000138	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—APOB—atherosclerosis	3.35e-05	0.000137	CbGpPWpGaD
Auranofin—IKBKB—Cytokine Signaling in Immune system—IL6—atherosclerosis	3.34e-05	0.000136	CbGpPWpGaD
Auranofin—ALB—Hemostasis—CD36—atherosclerosis	3.34e-05	0.000136	CbGpPWpGaD
Auranofin—ALB—Transmembrane transport of small molecules—HMOX1—atherosclerosis	3.33e-05	0.000136	CbGpPWpGaD
Auranofin—IKBKB—Immune System—CD36—atherosclerosis	3.31e-05	0.000135	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—IL6—atherosclerosis	3.28e-05	0.000134	CbGpPWpGaD
Auranofin—ALB—Metabolism—CYP27A1—atherosclerosis	3.25e-05	0.000132	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—CCR2—atherosclerosis	3.22e-05	0.000131	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—EDNRA—atherosclerosis	3.22e-05	0.000131	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—CYBA—atherosclerosis	3.21e-05	0.000131	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—LPL—atherosclerosis	3.2e-05	0.00013	CbGpPWpGaD
Auranofin—ALB—Transmembrane transport of small molecules—APOB—atherosclerosis	3.19e-05	0.00013	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—PARP1—atherosclerosis	3.14e-05	0.000128	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—GHRL—atherosclerosis	3.14e-05	0.000128	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—PLAT—atherosclerosis	3.14e-05	0.000128	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	3.12e-05	0.000127	CbGpPWpGaD
Auranofin—ALB—Platelet activation, signaling and aggregation—VEGFA—atherosclerosis	3.08e-05	0.000126	CbGpPWpGaD
Auranofin—ALB—Metabolism—ALOX15—atherosclerosis	3.08e-05	0.000126	CbGpPWpGaD
Auranofin—ALB—Metabolism—APOA2—atherosclerosis	3.08e-05	0.000126	CbGpPWpGaD
Auranofin—ALB—Metabolism—PLA2G2A—atherosclerosis	3.08e-05	0.000126	CbGpPWpGaD
Auranofin—ALB—Metabolism—ALOX5AP—atherosclerosis	3.08e-05	0.000126	CbGpPWpGaD
Auranofin—ALB—Hemostasis—PDGFB—atherosclerosis	3.08e-05	0.000126	CbGpPWpGaD
Auranofin—IKBKB—Immune System—PDGFB—atherosclerosis	3.06e-05	0.000125	CbGpPWpGaD
Auranofin—ALB—Hemostasis—MMP1—atherosclerosis	3.04e-05	0.000124	CbGpPWpGaD
Auranofin—ALB—Metabolism—ABCG5—atherosclerosis	3.04e-05	0.000124	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	3.04e-05	0.000124	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—AKT1—atherosclerosis	3.03e-05	0.000123	CbGpPWpGaD
Auranofin—IKBKB—Immune System—CRP—atherosclerosis	2.99e-05	0.000122	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—NFKB1—atherosclerosis	2.98e-05	0.000122	CbGpPWpGaD
Auranofin—ALB—Metabolism—LPA—atherosclerosis	2.94e-05	0.00012	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—MAPK8—atherosclerosis	2.93e-05	0.00012	CbGpPWpGaD
Auranofin—ALB—Hemostasis—CAV1—atherosclerosis	2.92e-05	0.000119	CbGpPWpGaD
Auranofin—ALB—Platelet activation, signaling and aggregation—MAPK3—atherosclerosis	2.92e-05	0.000119	CbGpPWpGaD
Auranofin—ALB—Hemostasis—APOA1—atherosclerosis	2.91e-05	0.000119	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—NFKB1—atherosclerosis	2.87e-05	0.000117	CbGpPWpGaD
Auranofin—IKBKB—Immune System—TLR4—atherosclerosis	2.86e-05	0.000117	CbGpPWpGaD
Auranofin—ALB—Metabolism—BGN—atherosclerosis	2.85e-05	0.000116	CbGpPWpGaD
Auranofin—ALB—Platelet activation, signaling and aggregation—TGFB1—atherosclerosis	2.83e-05	0.000115	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	2.83e-05	0.000115	CbGpPWpGaD
Auranofin—ALB—Metabolism—APOA5—atherosclerosis	2.82e-05	0.000115	CbGpPWpGaD
Auranofin—ALB—Hemostasis—F2—atherosclerosis	2.78e-05	0.000113	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—KNG1—atherosclerosis	2.76e-05	0.000112	CbGpPWpGaD
Auranofin—IKBKB—Immune System—ICAM1—atherosclerosis	2.75e-05	0.000112	CbGpPWpGaD
Auranofin—ALB—Hemostasis—NOS2—atherosclerosis	2.75e-05	0.000112	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—AGTR1—atherosclerosis	2.74e-05	0.000112	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	2.74e-05	0.000112	CbGpPWpGaD
Auranofin—ALB—Metabolism—PLA2G1B—atherosclerosis	2.71e-05	0.000111	CbGpPWpGaD
Auranofin—ALB—Transmembrane transport of small molecules—PPARA—atherosclerosis	2.69e-05	0.00011	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	2.68e-05	0.000109	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—PLG—atherosclerosis	2.67e-05	0.000109	CbGpPWpGaD
Auranofin—ALB—Hemostasis—PIK3CG—atherosclerosis	2.66e-05	0.000108	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	2.66e-05	0.000108	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	2.65e-05	0.000108	CbGpPWpGaD
Auranofin—ALB—Metabolism—ALOX5—atherosclerosis	2.62e-05	0.000107	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—MAPK3—atherosclerosis	2.56e-05	0.000104	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—SOCS3—atherosclerosis	2.53e-05	0.000103	CbGpPWpGaD
Auranofin—ALB—Transmembrane transport of small molecules—APOA1—atherosclerosis	2.52e-05	0.000103	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—MMP3—atherosclerosis	2.44e-05	9.96e-05	CbGpPWpGaD
Auranofin—ALB—Hemostasis—IGF1—atherosclerosis	2.43e-05	9.92e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—IGF2—atherosclerosis	2.43e-05	9.91e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	2.42e-05	9.86e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—APOB—atherosclerosis	2.36e-05	9.62e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—NAMPT—atherosclerosis	2.35e-05	9.58e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	2.34e-05	9.52e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—LIPC—atherosclerosis	2.33e-05	9.52e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—EDN1—atherosclerosis	2.32e-05	9.47e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—APOC3—atherosclerosis	2.32e-05	9.46e-05	CbGpPWpGaD
Auranofin—ALB—Hemostasis—SERPINE1—atherosclerosis	2.31e-05	9.42e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—LDLR—atherosclerosis	2.31e-05	9.4e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—CCL5—atherosclerosis	2.31e-05	9.4e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—LPL—atherosclerosis	2.25e-05	9.19e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—CETP—atherosclerosis	2.25e-05	9.18e-05	CbGpPWpGaD
Auranofin—ALB—Hemostasis—NOS3—atherosclerosis	2.21e-05	8.99e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—PRKCG—atherosclerosis	2.19e-05	8.93e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—SCARB1—atherosclerosis	2.16e-05	8.79e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—SPP1—atherosclerosis	2.14e-05	8.7e-05	CbGpPWpGaD
Auranofin—IKBKB—Immune System—IFNG—atherosclerosis	2.09e-05	8.51e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—HMGCR—atherosclerosis	2.04e-05	8.3e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—PDGFB—atherosclerosis	1.98e-05	8.05e-05	CbGpPWpGaD
Auranofin—ALB—Platelet activation, signaling and aggregation—AKT1—atherosclerosis	1.97e-05	8.02e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—AGT—atherosclerosis	1.93e-05	7.86e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—LEP—atherosclerosis	1.89e-05	7.7e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—APOE—atherosclerosis	1.89e-05	7.7e-05	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—IL6—atherosclerosis	1.87e-05	7.63e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—CAV1—atherosclerosis	1.87e-05	7.63e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—APOA1—atherosclerosis	1.87e-05	7.61e-05	CbGpPWpGaD
Auranofin—IKBKB—Immune System—IL1B—atherosclerosis	1.86e-05	7.59e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	1.84e-05	7.49e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—ABCA1—atherosclerosis	1.82e-05	7.4e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—ESR1—atherosclerosis	1.8e-05	7.35e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—F2—atherosclerosis	1.78e-05	7.26e-05	CbGpPWpGaD
Auranofin—IKBKB—Immune System—NFKB1—atherosclerosis	1.74e-05	7.08e-05	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—AKT1—atherosclerosis	1.73e-05	7.04e-05	CbGpPWpGaD
Auranofin—IKBKB—Immune System—MAPK8—atherosclerosis	1.71e-05	6.96e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—PIK3CG—atherosclerosis	1.71e-05	6.95e-05	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—AKT1—atherosclerosis	1.66e-05	6.76e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—INS—atherosclerosis	1.61e-05	6.58e-05	CbGpPWpGaD
Auranofin—ALB—Hemostasis—VEGFA—atherosclerosis	1.59e-05	6.48e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—CCL2—atherosclerosis	1.59e-05	6.47e-05	CbGpPWpGaD
Auranofin—IKBKB—Immune System—STAT3—atherosclerosis	1.56e-05	6.37e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—IGF1—atherosclerosis	1.56e-05	6.36e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—HMOX1—atherosclerosis	1.56e-05	6.35e-05	CbGpPWpGaD
Auranofin—ALB—Hemostasis—MAPK3—atherosclerosis	1.5e-05	6.13e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—APOB—atherosclerosis	1.49e-05	6.08e-05	CbGpPWpGaD
Auranofin—IKBKB—Immune System—MAPK3—atherosclerosis	1.49e-05	6.08e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—SERPINE1—atherosclerosis	1.48e-05	6.04e-05	CbGpPWpGaD
Auranofin—ALB—Hemostasis—TGFB1—atherosclerosis	1.46e-05	5.95e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—GSTM1—atherosclerosis	1.45e-05	5.92e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—LPL—atherosclerosis	1.42e-05	5.81e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—NOS3—atherosclerosis	1.42e-05	5.77e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—GPX1—atherosclerosis	1.39e-05	5.67e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—CD36—atherosclerosis	1.35e-05	5.52e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—MTHFR—atherosclerosis	1.28e-05	5.23e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—PPARA—atherosclerosis	1.26e-05	5.13e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—CXCL8—atherosclerosis	1.26e-05	5.12e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—AGT—atherosclerosis	1.22e-05	4.97e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—APOE—atherosclerosis	1.19e-05	4.87e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—CAV1—atherosclerosis	1.18e-05	4.82e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—APOA1—atherosclerosis	1.18e-05	4.81e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—MMP9—atherosclerosis	1.14e-05	4.63e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—NFKB1—atherosclerosis	1.12e-05	4.58e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—MAPK8—atherosclerosis	1.1e-05	4.5e-05	CbGpPWpGaD
Auranofin—IKBKB—Immune System—IL6—atherosclerosis	1.09e-05	4.45e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—PIK3CG—atherosclerosis	1.08e-05	4.39e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—PPARG—atherosclerosis	1.04e-05	4.24e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—INS—atherosclerosis	1.02e-05	4.16e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—VEGFA—atherosclerosis	1.02e-05	4.16e-05	CbGpPWpGaD
Auranofin—ALB—Hemostasis—AKT1—atherosclerosis	1.01e-05	4.13e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—STAT3—atherosclerosis	1.01e-05	4.12e-05	CbGpPWpGaD
Auranofin—IKBKB—Immune System—AKT1—atherosclerosis	1.01e-05	4.1e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—MAPK3—atherosclerosis	9.65e-06	3.93e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—TGFB1—atherosclerosis	9.36e-06	3.81e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—NOS3—atherosclerosis	8.95e-06	3.65e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—PTGS2—atherosclerosis	8.18e-06	3.34e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—IL6—atherosclerosis	7.05e-06	2.87e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—AKT1—atherosclerosis	6.51e-06	2.65e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—AKT1—atherosclerosis	4.11e-06	1.68e-05	CbGpPWpGaD
